BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 23407373)

  • 1. Blood pressure and chronic kidney disease progression in a multi-racial cohort: the Multi-Ethnic Study of Atherosclerosis.
    Bloomfield GS; Yi SS; Astor BC; Kramer H; Shea S; Shlipak MG; Post WS
    J Hum Hypertens; 2013 Jul; 27(7):421-6. PubMed ID: 23407373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Metabolic Syndrome with Chronic Kidney Disease in Elderly Japanese Women: Comparison by Estimation of Glomerular Filtration Rate from Creatinine, Cystatin C, and Both.
    Kurata M; Tsuboi A; Takeuchi M; Fukuo K; Kazumi T
    Metab Syndr Relat Disord; 2016 Feb; 14(1):40-5. PubMed ID: 26535975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of the creatinine and cystatin C-based equations for estimation of GFR in Chinese patients with chronic kidney disease.
    Yang M; Xu G; Ling L; Niu J; Lu T; Du X; Gu Y
    Clin Exp Nephrol; 2017 Apr; 21(2):236-246. PubMed ID: 27125433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pretransplant renal function according to CKD-EPI cystatin C equation is a prognostic factor of death after liver transplantation.
    Uguen T; Jezequel C; Ropert M; Houssel-Debry P; Latournerie M; Lainé F; Deugnier Y; Vigneau C; Boudjema K; Guyader D; Bardou-Jacquet E
    Liver Int; 2016 Apr; 36(4):547-54. PubMed ID: 26502295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NT-proBNP and troponin T and risk of rapid kidney function decline and incident CKD in elderly adults.
    Bansal N; Katz R; Dalrymple L; de Boer I; DeFilippi C; Kestenbaum B; Park M; Sarnak M; Seliger S; Shlipak M
    Clin J Am Soc Nephrol; 2015 Feb; 10(2):205-14. PubMed ID: 25605700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Estimated GFR Calculated Using Race-Free Equations With Kidney Failure and Mortality by Black vs Non-Black Race.
    Gutiérrez OM; Sang Y; Grams ME; Ballew SH; Surapaneni A; Matsushita K; Go AS; Shlipak MG; Inker LA; Eneanya ND; Crews DC; Powe NR; Levey AS; Coresh J;
    JAMA; 2022 Jun; 327(23):2306-2316. PubMed ID: 35667006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of chronic kidney diseases in patients with chronic obstructive pulmonary disease: assessment based on glomerular filtration rate estimated from creatinine and cystatin C levels.
    Yoshizawa T; Okada K; Furuichi S; Ishiguro T; Yoshizawa A; Akahoshi T; Gon Y; Akashiba T; Hosokawa Y; Hashimoto S
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1283-9. PubMed ID: 26185434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for CKD progression in Japanese patients: findings from the Chronic Kidney Disease Japan Cohort (CKD-JAC) study.
    Inaguma D; Imai E; Takeuchi A; Ohashi Y; Watanabe T; Nitta K; Akizawa T; Matsuo S; Makino H; Hishida A;
    Clin Exp Nephrol; 2017 Jun; 21(3):446-456. PubMed ID: 27412450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison between Different Measures of Body Fat with Kidney Function Decline and Incident CKD.
    Madero M; Katz R; Murphy R; Newman A; Patel K; Ix J; Peralta C; Satterfield S; Fried L; Shlipak M; Sarnak M
    Clin J Am Soc Nephrol; 2017 Jun; 12(6):893-903. PubMed ID: 28522656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic kidney disease predicts coronary plaque vulnerability: an optical coherence tomography study.
    Dai J; Xing L; Hou J; Jia H; Hu S; Tian J; Lin L; Li L; Zhu Y; Zheng G; Zhang S; Yu B; Jang IK
    Coron Artery Dis; 2017 Mar; 28(2):135-144. PubMed ID: 27922522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Race and sex differences in hypertension control in CKD: results from the Kidney Early Evaluation Program (KEEP).
    Duru OK; Li S; Jurkovitz C; Bakris G; Brown W; Chen SC; Collins A; Klag M; McCullough PA; McGill J; Narva A; Pergola P; Singh A; Norris K
    Am J Kidney Dis; 2008 Feb; 51(2):192-8. PubMed ID: 18215697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Examining the utility of cystatin C as a confirmatory test of chronic kidney disease across the age range in middle-aged and older community-dwelling adults.
    Canney M; Sexton DJ; O'Leary N; Healy M; Kenny RA; Little MA; O'Seaghdha CM
    J Epidemiol Community Health; 2018 Apr; 72(4):287-293. PubMed ID: 29332011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New Creatinine- and Cystatin C-Based Equations to Estimate GFR without Race.
    Inker LA; Eneanya ND; Coresh J; Tighiouart H; Wang D; Sang Y; Crews DC; Doria A; Estrella MM; Froissart M; Grams ME; Greene T; Grubb A; Gudnason V; Gutiérrez OM; Kalil R; Karger AB; Mauer M; Navis G; Nelson RG; Poggio ED; Rodby R; Rossing P; Rule AD; Selvin E; Seegmiller JC; Shlipak MG; Torres VE; Yang W; Ballew SH; Couture SJ; Powe NR; Levey AS;
    N Engl J Med; 2021 Nov; 385(19):1737-1749. PubMed ID: 34554658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of measured GFR, serum creatinine, cystatin C, and beta-trace protein to predict ESRD in African Americans with hypertensive CKD.
    Bhavsar NA; Appel LJ; Kusek JW; Contreras G; Bakris G; Coresh J; Astor BC;
    Am J Kidney Dis; 2011 Dec; 58(6):886-93. PubMed ID: 21944667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma Uromodulin Correlates With Kidney Function and Identifies Early Stages in Chronic Kidney Disease Patients.
    Steubl D; Block M; Herbst V; Nockher WA; Schlumberger W; Satanovskij R; Angermann S; Hasenau AL; Stecher L; Heemann U; Renders L; Scherberich J
    Medicine (Baltimore); 2016 Mar; 95(10):e3011. PubMed ID: 26962815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low serum bicarbonate and kidney function decline: the Multi-Ethnic Study of Atherosclerosis (MESA).
    Driver TH; Shlipak MG; Katz R; Goldenstein L; Sarnak MJ; Hoofnagle AN; Siscovick DS; Kestenbaum B; de Boer IH; Ix JH
    Am J Kidney Dis; 2014 Oct; 64(4):534-41. PubMed ID: 24953891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for CKD To Improve Processes of Care among Nondiabetic Veterans with Hypertension: A Pragmatic Cluster-Randomized Trial.
    Peralta CA; Frigaard M; Rolon L; Seal K; Tuot D; Senyak J; Lo L; Powe N; Scherzer R; Chao S; Chiao P; Lui K; Shlipak MG; Rubinsky AD
    Clin J Am Soc Nephrol; 2020 Feb; 15(2):174-181. PubMed ID: 32034070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The eGFR-C study: accuracy of glomerular filtration rate (GFR) estimation using creatinine and cystatin C and albuminuria for monitoring disease progression in patients with stage 3 chronic kidney disease--prospective longitudinal study in a multiethnic population.
    Lamb EJ; Brettell EA; Cockwell P; Dalton N; Deeks JJ; Harris K; Higgins T; Kalra PA; Khunti K; Loud F; Ottridge RS; Sharpe CC; Sitch AJ; Stevens PE; Sutton AJ; Taal MW;
    BMC Nephrol; 2014 Jan; 15():13. PubMed ID: 24423077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combining Cystatin C and Creatinine Yields a Reliable Glomerular Filtration Rate Estimation in Older Adults in Contrast to β-Trace Protein and β2-Microglobulin.
    Werner K; Pihlsgård M; Elmståhl S; Legrand H; Nyman U; Christensson A
    Nephron; 2017; 137(1):29-37. PubMed ID: 28407629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of chronic kidney disease with creatinine, cystatin C, and urine albumin-to-creatinine ratio and association with progression to end-stage renal disease and mortality.
    Peralta CA; Shlipak MG; Judd S; Cushman M; McClellan W; Zakai NA; Safford MM; Zhang X; Muntner P; Warnock D
    JAMA; 2011 Apr; 305(15):1545-52. PubMed ID: 21482744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.